|CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER|
2 U-M oncologists selected to 'Ultimate Think Tank'
New Komen for the Cure Scientific Advisory Council to focus on innovative, most effective research in breast cancer science-added 8/13/10
Ann Arbor - Two breast cancer specialists from the University of Michigan Comprehensive Cancer Center were named to a "brain trust" of more than 60 top-ranking scientists, clinicians and advocates to guide the extensive research program of Susan G. Komen for the Cure®, the world's largest breast cancer organization.
Daniel F. Hayes, M.D. and Lori J. Pierce, M.D. will serve as inaugural members of Komen for the Cure's new Scientific Advisory Council (SAC) . They will provide scientific peer review for the breast cancer grants and programs that Komen funds on an annual basis.
The Scientific Advisory Council will also provide Komen leadership with guidance on breast cancer education and public policy. Susan G. Komen for the Cure, the largest source of breast cancer research funding outside of the U.S. government, currently funds nearly 760 active research grants around the world, with plans to invest another $59 million into 105 projects in 2010 alone.
Hayes is the Stuart B. Padnos Professor in Breast Cancer Research and clinical director of the Breast Oncology Program at U-M. Pierce is professor of radiation oncology and vice provost for academic and faculty affairs. Both are active in both treating breast cancer patients and conducting breast cancer research.
As researchers themselves, SAC members must demonstrate to Komen that they are involved in innovative projects that seek to discover and deliver the cures for breast cancer. Given that they are not eligible to apply for standard Komen grants, SAC members will be provided with the opportunity to receive funding for their academic institutions in amounts ranging from $175,000 to $250,000 on an annual basis for their work.
SAC members will serve two-year terms, which are also renewable.
U-M Cancer AnswerLine™, 800-865-1125
Breast Oncology Research Program
Clinical trials at U-M
Susan G. Komen for the Cure